Yong Gao (Gao Yong, Ming Quan)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Ischemia Reperfusion Injury

Transforming Growth Factor

Binding Protein

Epithelial Mesenchymal Transition

Top Venues

Pharmaceutical research

Cell death & disease

Medical oncology (Northwood, London, England)

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Li Li, Dacheng Xie, Shijun Yu, Muyuan Ma, Kailing Fan, Jingde Chen, Mengxi Xiu, Keping Xie, Yandong Li, Yong Gao
WNK1 Interaction with KEAP1 Promotes NRF2 Stabilization to Enhance the Oxidative Stress Response in Hepatocellular Carcinoma. Cancer research (2024)
Jingde Chen, Yanan Hai, Qingqing Hu, Chen Chen, Xiaohua Jiang, Yong Gao
TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer. Pharmaceutical research 40 (3) (2022)
Li Li, Shijun Yu, Jingde Chen, Ming Quan, Yong Gao, Yandong Li
miR-15a and miR-20b sensitize hepatocellular carcinoma cells to sorafenib through repressing CDC37L1 and consequent PPIA downregulation. Cell death discovery 8 (1) (2022)
Jingde Chen, Yanan Hai, Qingqing Hu, Chen Chen, Xiaohua Jiang, Yong Gao
TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer. Pharmaceutical research (2022)
Jingde Chen, Yanan Hai, Qingqing Hu, Chen Chen, Xiaohua Jiang, Yong Gao
TGF-β Signaling Activation Confers Anlotinib Resistance in Gastric Cancer. Pharmaceutical research 40 (3) (2022)
Mengxi Xiu, Li Li, Yandong Li, Yong Gao
An update regarding the role of WNK kinases in cancer. Cell death & disease 13 (9) (2022)
Jingde Chen, Ming Quan, Zhiqin Chen, Tianmei Zeng, Yandong Li, Ying Zhou, Yanan Hai, Yong Gao
Camrelizumab in advanced or metastatic solid tumour patients with DNA mismatch repair deficient or microsatellite instability high: an open-label prospective pivotal trial. Journal of cancer research and clinical oncology 146 (10) (2020)
Yandong Li, Shijun Yu, Li Li, Jingde Chen, Ming Quan, Qinchuan Li, Yong Gao
KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell death & disease 11 (4) (2020)
Haiyan Yang, Jiong Hu, Jingde Chen, Zhiqin Chen, Feng Jiao, Jiujie Cui, Yong Gao, Liwei Wang
RNA-binding protein Musashi2 regulates Hippo signaling via SAV1 and MOB1 in pancreatic cancer. Medical oncology (Northwood, London, England) 37 (9) (2020)